Sagimet Biosciences Inc. - 8-K Filing
On May 28, 2026, Sagimet Biosciences Inc. granted stock options and performance-based restricted stock units (PSUs) to its executives: David Happel received 300,000 options and 300,000 PSUs; Thierry Chauche was awarded 50,000 options and 50,000 PSUs; Elizabeth Rozek received 100,000 options and 100,000 PSUs. The awards vest over four years for the options and are tied to regulatory milestones for the PSUs. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $SGMT